Citation: | ZHANG Xiangjun, ZHU Jingrui, WANG Li, LI Jing. Research on the monitoring of pathogens and the prediction model of risk factors for hospital-acquired pneumonia in intensive care unit[J]. Chinese Journal of General Practice, 2023, 21(6): 1053-1055. doi: 10.16766/j.cnki.issn.1674-4152.003047 |
[1] |
夏品江, 张舸. 替加环素在多重或泛耐药鲍曼不动杆菌引起的重症医院获得性肺炎治疗中的运用价值[J]. 中华全科医学, 2017, 15(3): 404-406. doi: 10.16766/j.cnki.issn.1674-4152.2017.03.012
XIA P J, ZHANG G. The value of the application of tigecycline in the treatment of severe hospital acquired pneumonia caused by multiple or pan drug resistant Acinetobacter baumannii[J]. Chinese Journal of General Practice, 2017, 15(3): 404-406. doi: 10.16766/j.cnki.issn.1674-4152.2017.03.012
|
[2] |
黄琦, 王建林, 侯菊花. 改良式体位结合0.02%氯己定口腔护理对重症呼吸机相关性肺炎患者的预防效果[J]. 中华全科医学, 2018, 16(12): 2128-2130. doi: 10.16766/j.cnki.issn.1674-4152.000580
HUANG Q, WANG J L, HOU J H. Analysis of preventive effect of modified posture combined with 0. 02% chlorhexidine oral care on ventilator-associated pneumonia in critically ill patients[J]. Chinese Journal of General Practice, 2018, 16(12): 2128-2130. doi: 10.16766/j.cnki.issn.1674-4152.000580
|
[3] |
MARTIN L I, RODRIGUEZ A H, TORRES A. New guidelines for hospital-acquired pneumonia/ventilator-associated pneumonia: USA vs. Europe[J]. Curr Opin Crit Care, 2018, 24(5): 347-352. doi: 10.1097/MCC.0000000000000535
|
[4] |
SHI Y, HUANG Y, ZHANG T T, et al. Chinese guidelines for the diagnosis and treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in adults (2018 Edition)[J]. J Thorac Dis, 2019, 11(6): 2581-2616. doi: 10.21037/jtd.2019.06.09
|
[5] |
王亚豪. 某医院2016—2019年住院患者肺部感染病原菌分布及影响因素[J]. 江苏预防医学, 2021, 32(3): 339-341. https://www.cnki.com.cn/Article/CJFDTOTAL-JSYF202103032.htm
WANG Y H. Pathogenic bacteria distribution and influencing factors of pulmonary infection in hospitalized patients in a hospital from 2016 to 2019[J]. Jiangsu Journal of Preventive Medicine, 2021, 32(3): 339-341. https://www.cnki.com.cn/Article/CJFDTOTAL-JSYF202103032.htm
|
[6] |
LIU B, LI S, LI H T, et al. Outcomes and prognostic factors of tigecycline treatment for hospital-acquired pneumonia involving multidrug-resistant Acinetobacter baumanii[J]. J Int Med Res, 2020, 48(4): 30-48.
|
[7] |
李金秀, 夏天, 潘童. 头孢哌酮舒巴坦钠与替加环素联合治疗ICU泛耐药鲍曼不动杆菌呼吸道感染的临床疗效及安全性[J]. 中国临床研究, 2017, 30(7): 886-889. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGCK201707006.htm
LI J X, XIA T, PAN T. Clinical efficacy and safety of cefoperazone sulbactam sodium combined with tigecycline in treatment of respiratory tract infection of pan-drug-resistant Acinetobacter baumannii in ICU[J]. Chinese Journal of Clinical Research, 2017, 30(7): 886-889. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGCK201707006.htm
|
[8] |
O'HARA L M, CALFEE D P, MILLER L G, et al. Optimizing contact precautions to curb the spread of antibiotic-resistant bacteria in hospitals: a multicenter cohort study to identify patient characteristics and healthcare personnel interactions associated with transmission of methicillin-resistant staphylococcus aureus[J]. Clin Infect Dis, 2019, 69(Suppl3): S171-S177.
|
[9] |
BLANCO N, JOHNSON J K, SORKIN J D, et al. Transmission of resistant Gram-negative bacteria to healthcare personnel gowns and gloves during care of residents in community-based nursing facilities[J]. Infect Control Hosp Epidemiol, 2018, 39(12): 1425-1430. doi: 10.1017/ice.2018.247
|
[10] |
SANO M, SHINDO Y, TAKAHASHI K, et al. Risk factors for antibiotic resistance in hospital-acquired and ventilator-associated pneumonia[J]. J Infect Chemother, 2022, 28(6): 745-752.
|
[11] |
王玲. 耐多药结核病患者并发营养不良与肺部感染相关性的分析[J]. 中国医药指南, 2018, 16(16): 103-104. https://www.cnki.com.cn/Article/CJFDTOTAL-YYXK201816072.htm
WANG L. Analysis of the correlation between malnutrition and pulmonary infection in patients with multi-drug resistant tuberculosis[J]. Guide of China Medicine, 2018, 16(16): 103-104. https://www.cnki.com.cn/Article/CJFDTOTAL-YYXK201816072.htm
|
[12] |
GIULIANO K K, BAKER D, QUINN B, et al. The epidemiology of nonventilator hospital-acquired pneumonia in the United States[J]. Am J Infect Control, 2018, 46(3): 322-327.
|
[13] |
郑凌, 高磊, 叶静, 等. 呼吸重症监护病房HAP致病菌耐药性及其相关因素分析[J]. 安徽医科大学学报, 2021, 56(1): 134-137. https://www.cnki.com.cn/Article/CJFDTOTAL-YIKE202101026.htm
ZHENG L, GAO L, YE J, et al. Analysis of drug resistance and related factors of pathogenic bacteria of HAP in RICU[J]. Acta Universitatis Medicinalis Anhui, 2021, 56(1): 134-137. https://www.cnki.com.cn/Article/CJFDTOTAL-YIKE202101026.htm
|
[14] |
YANG H J, FAN Y H, LI C H, et al. A retrospective study on risk factors and disease burden for hospital-acquired pneumonia caused by multi-drug-resistant bacteria in patients with intracranial cerebral hemorrhage[J]. Neurol Sci, 2022, 43(4): 2461-2467.
|
[15] |
霍盛红. 急诊气管插管后呼吸机相关性肺炎的危险因素分析[J]. 医药论坛杂志, 2019, 40(4): 41-43. https://www.cnki.com.cn/Article/CJFDTOTAL-HYYX201904014.htm
HUO S H. Risk factors of ventilator-associated pneumonia after emergency endotracheal intubation[J]. Journal of Medical Forum, 2019, 40(4): 41-43. https://www.cnki.com.cn/Article/CJFDTOTAL-HYYX201904014.htm
|